|
Volumn 58, Issue 5, 2003, Pages 358-359
|
Sublingual delivery of 17β-estradiol from cyclodextrin containing tablets
|
Author keywords
[No Author keywords available]
|
Indexed keywords
2 HYDROXYPROPYL BETA CYCLODEXTRIN;
CYCLODEXTRIN;
ESTRADIOL;
ADULT;
ARTICLE;
BLOOD SAMPLING;
CLINICAL TRIAL;
COMPLEX FORMATION;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CROSSOVER PROCEDURE;
DOSE RESPONSE;
DRUG ABSORPTION;
DRUG ADMINISTRATION ROUTE;
DRUG BIOAVAILABILITY;
DRUG BLOOD LEVEL;
DRUG DELIVERY SYSTEM;
DRUG FORMULATION;
DRUG HALF LIFE;
DRUG PENETRATION;
DRUG SOLUBILITY;
FEMALE;
FLUOROIMMUNOASSAY;
HUMAN;
HUMAN EXPERIMENT;
HYDROPHILICITY;
LIPID SOLUBILITY;
MOLECULAR WEIGHT;
MOUTH MUCOSA;
NORMAL HUMAN;
TABLET;
HALF LIFE TIME;
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
INTRANASAL DRUG ADMINISTRATION;
SUBLINGUAL DRUG ADMINISTRATION;
ADMINISTRATION, INTRANASAL;
ADMINISTRATION, SUBLINGUAL;
ADULT;
CHROMATOGRAPHY, HIGH PRESSURE LIQUID;
CYCLODEXTRINS;
ESTRADIOL;
FEMALE;
HALF-LIFE;
HUMANS;
TABLETS;
|
EID: 0037568123
PISSN: 00317144
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (8)
|
References (9)
|